Bo You

2.0k total citations
59 papers, 1.5k citations indexed

About

Bo You is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bo You has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 28 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Bo You's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (15 papers) and Extracellular vesicles in disease (13 papers). Bo You is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (15 papers) and Extracellular vesicles in disease (13 papers). Bo You collaborates with scholars based in China, Germany and United States. Bo You's co-authors include Yiwen You, Si Shi, Ying Shan, Lili Bao, Qicheng Zhang, Miao Gu, Huijun Yue, Xiaolei Cao, Jing Chen and Dong Liu and has published in prestigious journals such as Oncogene, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Bo You

56 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo You China 20 1.2k 940 188 139 132 59 1.5k
Massimiliano Mellone United Kingdom 19 693 0.6× 494 0.5× 514 2.7× 135 1.0× 202 1.5× 24 1.2k
Eva Allonca Spain 23 570 0.5× 269 0.3× 410 2.2× 158 1.1× 114 0.9× 46 1.1k
Muh Hwa Yang Taiwan 6 900 0.8× 753 0.8× 649 3.5× 132 0.9× 96 0.7× 8 1.4k
Qingfu Zhang China 22 816 0.7× 531 0.6× 377 2.0× 376 2.7× 128 1.0× 63 1.4k
Angela Celetti Italy 27 1.0k 0.9× 221 0.2× 561 3.0× 260 1.9× 115 0.9× 44 1.5k
Sana Yokoi Japan 21 870 0.7× 297 0.3× 498 2.6× 378 2.7× 122 0.9× 43 1.4k
Daisuke Kita Japan 18 459 0.4× 248 0.3× 159 0.8× 196 1.4× 77 0.6× 53 1.1k
Tetsuo Ito Japan 25 1.2k 1.0× 460 0.5× 485 2.6× 226 1.6× 90 0.7× 40 1.8k
Maher N. Younes United States 19 517 0.4× 169 0.2× 498 2.6× 158 1.1× 62 0.5× 21 1.1k
Carlo Dominici Italy 27 1.2k 1.0× 608 0.6× 445 2.4× 383 2.8× 127 1.0× 57 1.9k

Countries citing papers authored by Bo You

Since Specialization
Citations

This map shows the geographic impact of Bo You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo You more than expected).

Fields of papers citing papers by Bo You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo You. The network helps show where Bo You may publish in the future.

Co-authorship network of co-authors of Bo You

This figure shows the co-authorship network connecting the top 25 collaborators of Bo You. A scholar is included among the top collaborators of Bo You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo You. Bo You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ju, Feng, Jialei Weng, Ningbo Fan, et al.. (2025). AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5. Cell Death and Disease. 16(1). 483–483. 1 indexed citations
2.
Liu, Huiting, Haijuan Xiao, Ling Yuan, et al.. (2025). ITGB6 promotes tumor recurrence and metastasis by mediating the resistance of daughter cells of PGCCs to anoikis. Scientific Reports. 15(1). 33571–33571. 1 indexed citations
3.
Zhang, Wei, Yun Lei, Ting Zhang, et al.. (2025). IL-8 promotes pyroptosis through ERK pathway and mediates glucocorticoid resistance in chronic rhinosinusitis with nasal polyps. Inflammation Research. 74(1). 20–20. 2 indexed citations
4.
Lü, Yi, Xin Zhang, Miao Gu, et al.. (2025). LPAR3 and COL8A1, as matrix stiffness-related biomarkers, promote nasopharyngeal carcinoma metastasis by triggering EMT and angiogenesis. Cellular Signalling. 131. 111712–111712. 2 indexed citations
5.
Bao, Lili, Zhong Ming, Zixiang Zhang, et al.. (2024). Stiffness promotes cell migration, invasion, and invadopodia in nasopharyngeal carcinoma by regulating the WT‐CTTN level. Cancer Science. 115(3). 836–846. 3 indexed citations
6.
Yang, Zhiyuan, Siyu Zhang, Keying Li, et al.. (2024). The m6A demethylases FTO and ALKBH5 aggravate the malignant progression of nasopharyngeal carcinoma by coregulating ARHGAP35. Cell Death Discovery. 10(1). 43–43. 9 indexed citations
7.
Yao, Hui, Siyu Zhang, Yue Fan, et al.. (2023). RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis. Cellular Oncology. 46(4). 1031–1048. 9 indexed citations
8.
You, Bo, Ting Zhang, Wei Zhang, et al.. (2023). IGFBP2 derived from PO-MSCs promote epithelial barrier destruction by activating FAK signaling in nasal polyps. iScience. 26(3). 106151–106151. 4 indexed citations
9.
Bao, Lili, Qianqian Ren, Zixiang Zhang, et al.. (2023). SCARB1 in extracellular vesicles promotes NPC metastasis by co-regulating M1 and M2 macrophage function. Cell Death Discovery. 9(1). 323–323. 15 indexed citations
10.
You, Bo, Panpan Zhang, Miao Gu, et al.. (2022). Let-7i-5p promotes a malignant phenotype in nasopharyngeal carcinoma via inhibiting tumor-suppressive autophagy. Cancer Letters. 531. 14–26. 15 indexed citations
11.
Cheng, Tianyi, Siyu Zhang, Yan Ji, et al.. (2022). EBV promotes vascular mimicry of dormant cancer cells by potentiating stemness and EMT. Experimental Cell Research. 421(2). 113403–113403. 8 indexed citations
12.
Zhang, Kaiwen, Dong Liu, Jianmei Zhao, et al.. (2021). Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis. Cell Death and Disease. 12(6). 554–554. 38 indexed citations
13.
You, Bo, et al.. (2020). MicroRNA-223-3p regulates allergic inflammation by targeting INPP4A. Brazilian Journal of Otorhinolaryngology. 87(5). 591–600. 14 indexed citations
14.
Zhang, Wei, Ting Zhang, Jie Zhang, et al.. (2020). Exosomal miR‐22‐3p Derived from Chronic Rhinosinusitis with Nasal Polyps Regulates Vascular Permeability by Targeting VE‐Cadherin. BioMed Research International. 2020(1). 1237678–1237678. 15 indexed citations
15.
Shan, Ying, Bo You, Si Shi, et al.. (2018). Hypoxia-Induced Matrix Metalloproteinase-13 Expression in Exosomes from Nasopharyngeal Carcinoma Enhances Metastases. Cell Death and Disease. 9(3). 382–382. 109 indexed citations
16.
Bao, Lili, Mingming Tang, Qicheng Zhang, et al.. (2016). Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma. Biochemical and Biophysical Research Communications. 476(4). 467–474. 26 indexed citations
17.
You, Bo, Miao Gu, Xiaolei Cao, et al.. (2016). Clinical significance of ADAM10 expression in laryngeal carcinoma. Oncology Letters. 13(3). 1353–1359. 6 indexed citations
18.
You, Yiwen, Ying Shan, Jing Chen, et al.. (2015). Matrix metalloproteinase 13‐containing exosomes promote nasopharyngeal carcinoma metastasis. Cancer Science. 106(12). 1669–1677. 146 indexed citations
19.
Shan, Ying, Xingyu Li, Bo You, et al.. (2015). MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma. Oncology Reports. 34(4). 1943–1952. 38 indexed citations
20.
You, Yiwen, Hao Yao, Bo You, et al.. (2014). Clinical significance of HAX-1 expression in laryngeal carcinoma. Auris Nasus Larynx. 42(4). 299–304. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026